FI971171A0 - Koostumukset ja menetelmät syöttösolujen välittämien tulehdussairauksien hoitamiseksi - Google Patents
Koostumukset ja menetelmät syöttösolujen välittämien tulehdussairauksien hoitamiseksiInfo
- Publication number
- FI971171A0 FI971171A0 FI971171A FI971171A FI971171A0 FI 971171 A0 FI971171 A0 FI 971171A0 FI 971171 A FI971171 A FI 971171A FI 971171 A FI971171 A FI 971171A FI 971171 A0 FI971171 A0 FI 971171A0
- Authority
- FI
- Finland
- Prior art keywords
- compositions
- treatment
- methods
- inflammatory diseases
- mast cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C271/34—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31226994A | 1994-09-23 | 1994-09-23 | |
| PCT/US1995/011814 WO1996009297A1 (en) | 1994-09-23 | 1995-09-14 | Compositions and methods for treating mast-cell inflammatory condition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI971171A0 true FI971171A0 (fi) | 1997-03-20 |
| FI971171A FI971171A (fi) | 1997-03-20 |
Family
ID=23210670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI971171A FI971171A (fi) | 1994-09-23 | 1997-03-20 | Koostumukset ja menetelmät syöttösolujen välittämien tulehdussairauksien hoitamiseksi |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6022969A (et) |
| EP (1) | EP0782571A1 (et) |
| JP (1) | JPH10506390A (et) |
| KR (1) | KR970706267A (et) |
| CN (1) | CN1160398A (et) |
| AU (1) | AU694275B2 (et) |
| CA (1) | CA2200561A1 (et) |
| CZ (1) | CZ87097A3 (et) |
| EE (1) | EE03525B1 (et) |
| FI (1) | FI971171A (et) |
| HR (1) | HRP950499B1 (et) |
| HU (1) | HUT77770A (et) |
| IL (1) | IL115405A (et) |
| LT (1) | LT4234B (et) |
| LV (1) | LV11865B (et) |
| MX (1) | MX9702125A (et) |
| NO (1) | NO309605B1 (et) |
| NZ (1) | NZ294392A (et) |
| PL (1) | PL183552B1 (et) |
| RU (1) | RU2159229C2 (et) |
| SI (1) | SI9520101A (et) |
| SK (1) | SK37997A3 (et) |
| TW (1) | TW442478B (et) |
| WO (1) | WO1996009297A1 (et) |
| ZA (1) | ZA958028B (et) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ29799A3 (cs) * | 1996-07-30 | 1999-06-16 | Arris Pharmaceutical Corporation | Disubstituovaná cyklická sloučenina, způsob její výroby, farmaceutický přípravek a způsob léčení onemocnění živočicha |
| WO1998024886A1 (en) * | 1996-12-04 | 1998-06-11 | Brigham And Women's Hospital, Inc. | Mast cell protease that cleaves fibrinogen |
| US5955431A (en) * | 1997-02-05 | 1999-09-21 | Brigham And Women's Hospital, Inc. | Mast cell protease peptide inhibitors |
| AU8997498A (en) * | 1997-09-05 | 1999-03-29 | Yoshitomi Pharmaceutical Industries, Ltd. | Tryptase inhibitor |
| AU1208999A (en) * | 1997-11-10 | 1999-05-31 | Array Biopharma, Inc. | Compounds which inhibit tryptase activity |
| US6221914B1 (en) * | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
| WO1999040083A2 (de) * | 1998-02-06 | 1999-08-12 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Bifunktionelle tryptase-inhibitoren |
| US6613769B1 (en) | 1998-02-06 | 2003-09-02 | Max-Planck-Gesellschaft zur Föderung der Wissenschaften. e.V. | Tryptase inhibitors |
| EP1115731A2 (de) * | 1998-09-04 | 2001-07-18 | Byk Gulden Lomberg Chemische Fabrik GmbH | Neue pyranosen |
| US6362216B1 (en) | 1998-10-27 | 2002-03-26 | Array Biopharma Inc. | Compounds which inhibit tryptase activity |
| AU3731400A (en) * | 1999-03-05 | 2000-09-21 | Trustees Of University Technology Corporation, The | Methods and compositions useful in inhibiting apoptosis |
| US6849605B1 (en) * | 1999-03-05 | 2005-02-01 | The Trustees Of University Technology Corporation | Inhibitors of serine protease activity, methods and compositions for treatment of viral infections |
| US6673786B1 (en) * | 1999-08-10 | 2004-01-06 | Altana Pharma Ag | Tryptase inhibitors |
| AU778965B2 (en) * | 1999-09-14 | 2004-12-23 | Altana Pharma Ag | Tryptase inhibitors |
| GB9923710D0 (en) * | 1999-10-08 | 1999-12-08 | Proteus Molecular Design | Chemical compounds |
| WO2001036386A1 (fr) * | 1999-11-17 | 2001-05-25 | Sumitomo Pharmaceuticals Co., Ltd. | Traitement du diabete contenant un derive de dipiperazine |
| CA2392121A1 (en) * | 1999-12-20 | 2001-06-28 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tryptase inhibitors |
| US6815557B2 (en) | 1999-12-20 | 2004-11-09 | Altana Pharma Ag | Tryptase inhibitors |
| AU2001231030A1 (en) * | 2000-01-20 | 2001-07-31 | Amgen Inc | Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics |
| US20020045613A1 (en) * | 2000-04-27 | 2002-04-18 | Heinz Pauls | 1-aroyl-piperidinyl benzamidines |
| ATE273302T1 (de) * | 2001-01-31 | 2004-08-15 | Altana Pharma Ag | Diazocinderivate und deren verwendung als tryptase inhibitoren |
| WO2002066420A2 (en) * | 2001-02-21 | 2002-08-29 | Altana Pharma Ag | Tryptase inhibitors |
| WO2002066430A1 (en) | 2001-02-21 | 2002-08-29 | Altana Pharma Ag | Tryptase inhibitors |
| WO2002074733A2 (en) * | 2001-03-15 | 2002-09-26 | Altana Pharma Ag | Tryptase-inhibitors |
| WO2002074732A2 (en) * | 2001-03-15 | 2002-09-26 | Altana Pharma Ag | Tryptase-inhibitors |
| US6818787B2 (en) * | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7186855B2 (en) * | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7232924B2 (en) * | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| CA2450659A1 (en) | 2001-06-19 | 2002-12-27 | Altana Pharma Ag | Tryptase inhibitors |
| JP2005523883A (ja) * | 2001-12-13 | 2005-08-11 | 興和株式会社 | 遅延型過敏症予防・治療用医薬組成物 |
| WO2003075853A2 (en) | 2002-03-08 | 2003-09-18 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| TW200524849A (en) * | 2003-07-02 | 2005-08-01 | Hoffmann La Roche | Hydroxyalkylamide derivatives |
| US20050255154A1 (en) * | 2004-05-11 | 2005-11-17 | Lena Pereswetoff-Morath | Method and composition for treating rhinitis |
| TW200815351A (en) * | 2006-05-02 | 2008-04-01 | Astrazeneca Ab | Novel compounds |
| TWI414527B (zh) * | 2010-10-06 | 2013-11-11 | Ind Tech Res Inst | 異山梨糖醇衍生物及包含該衍生物之液晶顯示器 |
| CN102453037B (zh) * | 2010-10-25 | 2014-06-25 | 财团法人工业技术研究院 | 异山梨糖醇衍生物及包含该衍生物的液晶显示器 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR208414A1 (es) * | 1974-11-07 | 1976-12-27 | Rhone Poulenc Ind | Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2) |
| US4746737A (en) * | 1985-07-26 | 1988-05-24 | Kowa Co., Ltd. | Phenyl guanidinobenzoate derivatives which have protease inhibitory activity |
| KR100309616B1 (ko) * | 1993-03-12 | 2002-02-28 | 추후제출 | 면역중재된염증질환의치료를위한조성물및방법 |
| US5525623A (en) * | 1993-03-12 | 1996-06-11 | Arris Pharmaceutical Corporation | Compositions and methods for the treatment of immunomediated inflammatory disorders |
| EP0763016B1 (en) * | 1994-06-01 | 2000-01-26 | Axys Pharmaceuticals, Inc. | Compositions and methods for treating mast-cell mediated conditions |
-
1995
- 1995-09-14 JP JP8511002A patent/JPH10506390A/ja not_active Ceased
- 1995-09-14 RU RU97106347/04A patent/RU2159229C2/ru not_active IP Right Cessation
- 1995-09-14 US US08/522,157 patent/US6022969A/en not_active Expired - Fee Related
- 1995-09-14 EP EP95934993A patent/EP0782571A1/en not_active Withdrawn
- 1995-09-14 WO PCT/US1995/011814 patent/WO1996009297A1/en not_active Application Discontinuation
- 1995-09-14 EE EE9700089A patent/EE03525B1/et not_active IP Right Cessation
- 1995-09-14 CN CN95195191A patent/CN1160398A/zh active Pending
- 1995-09-14 SK SK379-97A patent/SK37997A3/sk unknown
- 1995-09-14 AU AU37180/95A patent/AU694275B2/en not_active Ceased
- 1995-09-14 CZ CZ97870A patent/CZ87097A3/cs unknown
- 1995-09-14 PL PL95319587A patent/PL183552B1/pl unknown
- 1995-09-14 KR KR1019970701960A patent/KR970706267A/ko not_active Application Discontinuation
- 1995-09-14 NZ NZ294392A patent/NZ294392A/xx unknown
- 1995-09-14 CA CA002200561A patent/CA2200561A1/en not_active Abandoned
- 1995-09-14 HU HU9702059A patent/HUT77770A/hu unknown
- 1995-09-14 MX MX9702125A patent/MX9702125A/es not_active IP Right Cessation
- 1995-09-14 SI SI9520101A patent/SI9520101A/sl unknown
- 1995-09-22 HR HR950499A patent/HRP950499B1/xx not_active IP Right Cessation
- 1995-09-22 IL IL11540595A patent/IL115405A/en not_active IP Right Cessation
- 1995-09-22 ZA ZA958028A patent/ZA958028B/xx unknown
- 1995-09-26 TW TW084110031A patent/TW442478B/zh active
-
1997
- 1997-03-20 FI FI971171A patent/FI971171A/fi unknown
- 1997-03-20 NO NO971305A patent/NO309605B1/no unknown
- 1997-04-10 LT LT97-065A patent/LT4234B/lt not_active IP Right Cessation
- 1997-04-22 LV LVP-97-70A patent/LV11865B/en unknown
-
1999
- 1999-03-29 US US09/280,227 patent/US6211228B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL115405A (en) | 2002-07-25 |
| LT4234B (en) | 1997-10-27 |
| EE03525B1 (et) | 2001-10-15 |
| CA2200561A1 (en) | 1996-03-28 |
| WO1996009297A1 (en) | 1996-03-28 |
| SK37997A3 (en) | 1998-12-02 |
| PL319587A1 (en) | 1997-08-18 |
| IL115405A0 (en) | 1995-12-31 |
| LV11865A (lv) | 1997-10-20 |
| NO971305L (no) | 1997-05-06 |
| TW442478B (en) | 2001-06-23 |
| JPH10506390A (ja) | 1998-06-23 |
| HRP950499A2 (en) | 1997-08-31 |
| US6022969A (en) | 2000-02-08 |
| RU2159229C2 (ru) | 2000-11-20 |
| ZA958028B (en) | 1996-04-18 |
| PL183552B1 (pl) | 2002-06-28 |
| FI971171A (fi) | 1997-03-20 |
| AU3718095A (en) | 1996-04-09 |
| NO309605B1 (no) | 2001-02-26 |
| KR970706267A (ko) | 1997-11-03 |
| HRP950499B1 (en) | 2003-04-30 |
| SI9520101A (en) | 1997-12-31 |
| NO971305D0 (no) | 1997-03-20 |
| HUT77770A (hu) | 1998-08-28 |
| EP0782571A1 (en) | 1997-07-09 |
| CZ87097A3 (en) | 1997-11-12 |
| MX9702125A (es) | 1998-04-30 |
| NZ294392A (en) | 1999-05-28 |
| LV11865B (en) | 1998-01-20 |
| AU694275B2 (en) | 1998-07-16 |
| EE9700089A (et) | 1997-10-15 |
| LT97065A (en) | 1997-08-25 |
| US6211228B1 (en) | 2001-04-03 |
| CN1160398A (zh) | 1997-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI971171A0 (fi) | Koostumukset ja menetelmät syöttösolujen välittämien tulehdussairauksien hoitamiseksi | |
| FI971969A (fi) | Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä | |
| FI970918A0 (fi) | Yhdisteet ja menetelmät syövän hoitamiseksi | |
| NO995095L (no) | Substituerte imidazoler nyttig ved behandlingen av inflammasjonssykdommer | |
| FI956242A (fi) | Solukytkin ja menetelmä solujen reitittämiseksi sen kautta | |
| DE69724016D1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege | |
| KR100344712B1 (ko) | 알러지성및염증성질환의치료에유용한화합물 | |
| NO994778D0 (no) | FremgangsmÕter og sammensetninger for behandling av tarmbetennelse | |
| FI942643A0 (fi) | Menetelmä ja laite biosähköisten virtalähteiden dedusoimiseksi | |
| FI990171A0 (fi) | Uusia yhdisteitä ja koostumuksia tryptaasiaktiivisuuden liittyvien tautien hoitamiseksi | |
| FI940509A (fi) | Menetelmä normaalin ja ultrahienon sementin valmistamiseksi | |
| FI962370A (fi) | Laite tissuen valmistamiseksi | |
| FI971750A0 (fi) | Koostumuksia multippeliskleroosia varten ja sen hoito | |
| FI19992807A (fi) | Menetelmä ja järjestely häiriön poistamiseksi | |
| FI925327A (fi) | Foerfarande foer vaord av inflammation och i dessa anvaendbara foereningar och kompositioner | |
| FI962976A0 (fi) | Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta-salpaajaa | |
| FI971138A0 (fi) | Keraamisia eristeitä ja menetelmiä niiden muodostamiseksi | |
| FI943213A (fi) | Prosessi valmistaa 3-asyyliestratrieenejä ja asyylibentseenejä | |
| FI972694A0 (fi) | Uusi menetelmä sameridiinin valmistamiseksi | |
| AU8049098A (en) | Composition and methods for the treatment of inflammatory diseases | |
| FI944183A0 (fi) | TDMA-mottagare och foerfarande foer styrning av TDMA-mottagare | |
| ITRE950065A0 (it) | Procedimento per fabbricare giranti chiuse e attrezzatura per attuare il procedimento suddetto | |
| FI942293A0 (fi) | Foerfarande och anordning foer anvaendning i samband med placering av invecklingsmaterial pao ett foeremaol | |
| KR950031846U (ko) | 반두용 지지대의 구조 | |
| FI103753B (fi) | Menetelmä väkirehun käsittelemiseksi |